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Abstract A novel protein, belonging to the yeast family of FKBPs (FK-binding proteins), FKBP-70, was isolated from Saccharomyces cerevisiae 
by its interaction with the immunosuppressive agent FK-520. Its structural gene, FPR3, was cloned and the protein expressed and purified from 
Escherichia coli. This third member of the FKBP family in yeast is homologous to the other FKBPs at its carboxy terminus, showing conserved ligand 
binding and proline isomerase regions. It is, however, a longer acidic protein with several potential nuclear targeting sequences and a region of 
homology to nucleolins. Yeast strains deleted for FPR3, as well as a triple deletion mutant of this family of genes, FPRI, FPR2 and FPR3, are viable 
under normal conditions of growth, indicating that the FPR genes are not essential for life. 
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1. Introduction 
The immunosuppressive macrolides, FK-506 and its deriva- 
tive FK-520 (ascomycin) interfere with T-cell activation. These 
agents promote the association of a cytosolic binding protein 
FKBP-12 and the type 2B phosphatase calcineurin, inhibiting 
its activity. Calcineurin is thought to be required for 
dephosphorylation and nuclear translocation of NF-AT, a pos- 
itive transcription factor for lymphokine IL-2. The immuno- 
suppressive cyclic peptide cyclosporin A (CsA), extensively 
used in organ transplantation, also inhibits calcineurin in asso- 
ciation with its binding protein, cyclophilin (for general reviews 
see [ 1,2]). In addition, several novel proteins that bind to either 
FK-derivatives or CsA, collectively termed imtnunophilins, 
have been identified in many species from prokaryotes to man. 
They constitute two highly conserved protein families [3]. The 
peptidyl-prolyl cis-tram isomerase (PPIase or rotamase) activ- 
ity associated with these irnmunophilins is inhibited by the 
respective ligands and is thought to play a role in protein fold- 
ing [4]. Biochemical and genetic studies in yeast have also iden- 
tified immunophilins and demonstrated that the activity of the 
immunosuppressive agents in yeast is analogous to their activ- 
ity in mammalian cells [5-71. At present, a cytosolic FKBP-12 
[8], and an endoplasmic reticulum-associated FKBP-13 [9] have 
been identified. We have now isolated a novel protein, FKBP- 
70, a third member of the FKBP family by ascomycin affinity 
chromatography. We report the partial FKBP-70 protein se- 
quence, the complete primary sequence of the gene, FPR3, and 
the encoded protein as well as its expression in E. coli. We show 
by gene disruption experiments that the presence of FKBP-70 
is not essential for life and in addition that yeast strains simul- 
taneously disrupted for all three FPR genes are viable. 
*Corresponding author. Fax: (41) (61) 324 2990. 
2. Materials and methods 
2. I. Microbial strains 
Diploid (ala) and haploid (a and a) derivatives of JK93d (led-3,112. 
hisl, trpl, ura3-52, rmel) and MH287 a/a, JHZ-lba and JH2-lea 
(derived from the respective JK93d strains by introduction of the 
fprl::ADEZ disruption) were previously described [IO]. JH49B is a 
derivative of JK93d ala with cprl::LEUZ and fprl:: URA3 disruptions 
(a gift of J. Heitman). The following strains were constructed for this 
work: RH211, derived from JK93da by introducing the fpr3::LEU2 
disruption; RH20la, derived from JK93da by introducing the 
fpr2:: URA3 disruption, and RH202a, derived from JH2-lc by intro- 
ducing the fpr3::LEUZ disruption. RH205a is the RH201 derivative 
with all three FPR gene disruptions, fprl::ADEZ, fpr2::URA3 and 
fpA::LEUZ. 
2.2. General protocols 
All procedures employing E. coli (strain JM 109) and other molecular 
biology protocols were from Sambrook et al. [l 11. Yeast protocols were 
those decribed in [12]. DNA sequencing was performed using the Phar- 
macia T7 sequencing kit. PCR protocols were according to the instruc- 
tions included in the GeneAMP kit (Perkin-Elmer). 
2.3. Protein purification and sequencing 
An affinity resin was prepared by incubating 25 ml Affigel-10 (Bio- 
Rad) and 30 mg of 32-O-(3-amino-propanoyl)-ascomycin in 25 ml of 
10 mM NaBO, pH 8.5, 50% v/v ethanol overnight. The resin was 
quenched with 1 M ethanolamine-HCl pH 8.5, 50% ethanol, washed 
using alternating cycles of 5 mM glycine-HCI pH 2.5 or 0.5 M NaCl, 
20 mM Tris-HCI pH 8.0, and then stored in 100% ethanol at -20°C 
until use. 
A 5-1 yeast culture was harvested in the exponential growth phase and 
cells were lysed using Zymolyase (Seikagaku, Japan). Homogenization 
was performed in buffer A (10 mM Tris-HCl pH 7.5, 150 mM NaCI, 
1% w/v Triton X-100, 5 mM /3-mercaptoethanol, 1 mM EDTA, and 
protease inhibitors (0.5 mM Pefabloc, 5 &ml soybean trypsin inhibi- 
tor, 2 .@ml antipain, 5 .@rnl leupeptin, 1 mM benzamidine) using a 
Dounce homogenizer. A precleared cell extract (250 ml) was prepared 
and loaded onto a 5 ml affinity column, equilibrated in buffer A without 
the protease inhibitors. The column was washed with 250 ml buffer A 
containing 0.1% T&on X-100, and then with detergent-free buffer. 
Elution was with 20 mM glycine-HCI pH 2.5; the fractions were imme- 
diately neutralized with Na-phosphate buffer and then analyzed by 
reducing SDS-PAGE. For protein sequencing, the peak fractions 
(40 pg FKBP-70) were precipitated using trichloroacetic acid (10% 
w/v), and run on 12.5% polyacrylamide gels. These were then blotted 
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onto PVDF membranes, the proteins detected by Coomassie-blue stain- 
ing, and the appropriate bands excised [13]. Sequencing was done on 
an ABI 470A gas phase protein sequencer. N-terminal sequencing was 
attempted irectly from the blotted material using the method devel- 
oped by Shively et al. [14]. For sequences of internal peptides, the 
membrane pieces were first incubated with I ml 0.5% (w/v) polyvinylpy- 
rolidone for 30 min at room temperature, washed once with 100% 
methanol and four times with water. Lys-C protease was added at 
100th (w/w) the estimated amount of blotted protein, and incubated 
overnight with the membrane in 200 ul 100 mM Tris-HCl nH 8.1 at 
37°C. The peptides were solubilized by adding guanidiniumtHC1, be- 
fore the sample volume was reduced to 180~1 using a speed-vat concen- 
trator (final guanidium- HCl concentration was 6 M). The material was 
then treated with 100 equivalents of dithiothreitol dissolved in 10 ~1 6 
M guanidium-HCL0.5 M Tris-HCI pH 8.1 (buffer B) under argon for 
one hour at 37°C and furthermore with 300 equivalents of iodoacet- 
amide dissolved in 10~1 buffer B for 30 min at room temperature, again 
under argon and in the dark. The supematant was then injected onto 
reverse phase HPLC (Applied Biosystems 130A system equipped with 
a Brownlee RP 300 C8 column, 2.1 x 30 mm) and eluted with a gradient 
of solvents A and B (solvent A: 0.1% (v/v) trifluoroacetic acid (TFA); 
solvent B: 70% (v/v) acetonitrile, 30% water, 0.08% TFA): O-10 min 0% 
B, 1 l-30 min O-60% B, 3140 min 6&100% B. The peaks were collected 
manually and the material from individual peaks was applied directly 
to precycled glassfilter disks (exposed to 3 mg Polybrene) for sequenc- 
ing. PTH amino acid analysis was performed using an on-line ABI 
120A PTH analyzer. 
Recombinant FKBP-70 was purified from a l-l culture of E. coli 
W311OC’ that was induced for expression of this protein by shifting an 
exponentially growing culture from 30°C to 42°C and continued incu- 
bation for 3 h. Bacterial pellet was lysed in the presence of I mg/ml 
lysozyme, 20% w/v Sucrose and 30 mM Tris-HCl pH 8.0 for 15 min on 
ice. The suspension was then diluted IO-fold in buffer A and treated 
subsequently as detailed for the preparation from yeast. 
2.4. Generation of PCR probes, library screening and gene isolation 
Two degenerate oligonucleotides designed from two internal peptide 
sequences were used in a PCR with yeast chromosomal DNA as tem- 
plate: a sense oligonucleotide, 5’-TGG GAY ATY GGI GTK GCY 
GGI ATG TC-3’ (from peptide WDIGVAGMS) and an antisense 
oligonucleotide 5’-GC WGG RAT ICC WGG HAR RGC TTG3 
(from peptide QALPGIPA), where Y = C or T, I = lnosine, K = G or 
T, W = A or T, H = A or C or T, and R = A or G. The resulting 124 
bp PCR fragment was subcloned into Bluescript SK’ vector (Strat- 
agene) and sequenced using adjacent primers. Based on the internal 
DNA sequence unique to this fragment, two novel oligonucleotides 
with the sequence 5’-GTTGGTGGCGAACGTAGAATCA-3’ (bases 
26262647, Fig. 2) and 5’-GGAATACCTGGCAGAGCTTGCT-3 
(complimentary sequence to bases 2675-2696, Fig. 2) were synthesized 
and utilized in PCR with the parent vector as template to generate a 
70 bp product. A radioactive probe of this fragment obtained by ran- 
dom primer labelling was used to screen a cosmid library of yeast 
genomic DNA in the E. coli vector pWEl5 (Stratagene). A positive 
cosmid clone containing yeast genomic DNA of approximately 35 kb 
was identified by hybridisation. This was mapped by restriction enzyme 
analysis and Southern hybridisation to the 70 bp probe. A 4 kb San- 
Not1 DNA fragment containing the protein coding sequence was sub- 
cloned into the pGEM5Zf’ vector (Promega), generating plasmid 
pFC1. A segment of yeast genomic DNA of 2943 bp was sequenced 
from this plasmid by the dideoxy sequencing method using adja- 
cent vector primers and several internal oligonucleotides (data not 
shown). 
2.5. Construction of E. coli plastnih for expression 
A sense oligonucleotide with the sequence S-GGGCCCGGATC- 
CATGGCTGATTTGTTACCACTA-3’ corresponding to the amino- 
terminal portion of the open reading frame and an antisense oligonucle- 
otide S-GTCGACGGATCCAAGCTTTCTAGACTAGTTTTTCA- 
TAGAAACCAA-3’ derived from the carboxy-terminal part were used 
in a PCR with the plasmid pFC1 as template. The product of nearly 
1250 bp containing the coding region (with encompassing Ncol and 
BamHl sites specified by the primers) was cloned into the E. coli expres- 
sion vector pL-RCV downstream from the thermoinducible lambda 
promoter pL. The resulting plasmid, pLFKBP-70 was introduced into 
the E. coli strain W31 IOC’ (carrying a temperature sensitive lambda 
repressor on its chromosome). Growth at high temperature (42°C) of 
this bacterial strain resulted in the production of recombinant FKBP-70 
(for a description of pL-RCV and subsequent protein induction meth- 
ods, see Lokker et al. [15]). 
2.6. Yeast plasmiris and strains deleted for structural genes 
A 2.2 kb DNA fragment specifying the complete FPR3 gene was 
obtained from plasmid pFC1 by treatment with restriction endonu- 
clease Hind111 and subcloned into the 2-micron vectors YEPlacll2 and 
YEPlacl95 and into the centromeric vectors YCPlac22 and YCPlacl 11 
[16], resulting in plasmids YPH 105, YPH 103, YPH 106 and YPH 76 
respectively. A 2.2 kb Xhol-San fragment from plasmid YEPl3 [12] 
specifying the LEU2 gene was cloned into the single Acclll site within 
the coding region of the FPR3 gene in plasmid pFC1, by treatment with 
Klenow enzyme prior to ligation. Plasmid pF70L, resulting from this 
ligation contained the LEU2 gene inserted within the FPR3 gene in 
antisense orientation, flanked on its 5’ and 3’ sides by FPR3 fragments 
of 1.3 and I kb, respectively. The entire region was reisolated from 
pF70L as a 4.5 kb DNA fragment upon treatment with Hind111 and 
transformed into yeast cells. The FPR2 gene disruptions contained a 
I .12 kb &al-Clal fragment from YEP24 [12], specifying the URA3 
gene, cloned into the structural gene between Pacl and Nael sites (thus 
replacing amino acid residues 30 to 80 of FKBP-13 ([9], and our unpub- 
lished results). Transformants were selected for growth on media lack- 
ing leucine. Chromosomal FPR gene disruptions were verified by re- 
striction analysis, Southern blotting and hybridization to labeled 
probes (data not shown). Diploid strains with confirmed disruptions 
were sporulated and dissected. Segregation of the inserted LEU2 gene 
was monitored both by testing growth on media lacking leucine and by 
Southern blotting of DNA prepared from the haploid progeny. Growth 
was assessed irectly on rich medium, at 14”, 20”, 30”, 37”, and 40°C 
and at 30°C in the presence of I M NaCI, 1 M sorbitol, 100 fig/ml 
FK-520 or 50 mM Tris-HCI pH 8.6 buffer to score for altered pheno- 
types. 
2.7. Computer analysis 
EMBL, Gen Bank, SWISSPROT, PIR data bases were accessed for 
analyses of proteins and nucleic acids using UW-GCG software. 
3. Results and discussion 
3.1. Purification and microsequencing of FKBP-70 
Affinity chromatography of yeast extract prepared from 
strain JH4-9B, lacking FKBP-12, reproducibly yielded three 
major bands in a Coomassie-stained SDS-polyacrylamide gel 
(Fig. lA, lane 4): a 70, 60 and 12 kDa species. The yield of the 
70 kDa protein was typically estimated to be in the range of 
100 pg with variable quantities of the 60 kDa and 12 kDa 
proteins. Direct sequencing of both the 70 and 60 kDa species 
was not possible due to blocked N-termini. The 12 kDa species 
was identified as the the YS24 gene product, the S22 protein 
[17] of the 40s small ribosomal subunit, based on its amino- 
terminal sequence. Copurification of this protein could have 
resulted from its interaction with either the ascomycin resin 
(even though this protein shows no homology to any known 
FKBPs) or with FKBPs bound to the column. Both 70 and 60 
kDa proteins were treated with Lys-C endoprotease and several 
resulting peptides were sequenced. Two peptides A and B of 
sequence GWDIGVAGMSVGGERRII (362-379, Fig. 2) and 
QALPGIPANSELTFD (389405, Fig. 2) were obtained from 
both the 70 kDa and 60 kDa species. This suggested that the 
60 kDa protein may have resulted from limited proteolysis of 
the 70 kDa FKBP during purification. Incidentally, sequencing 
of the peak fraction containing peptide A from the 70 kDa 
species also yielded a second minor sequence, 
RNPDFEDDDFLGGD (57-70, Fig. 2). Two additional pep- 
tide sequences, HPFDTPMGVEGEDEDEDADI (164-183, 
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Fig. 1. Purification of FKBP70. (A) Elution of yeast FKBP70 from the Ascomycin affinity resin. Fractions 4and 5 contain the majority of the material 
released bv low nH. (B) Comnarison of FJBP70 isolated from veast (lanes 1 and 2) and FKBP70 expressed in E. coli (lane 3). Sizes of molecular 
mass standards are indicated bn the left. 
Fig. 2) and VLEGGIVIEDRTIGDGPQ (303-320, Fig. 2) were 
obtained from the 70 kDa species. 
3.2. Isolation of the FPR3 gene and homology of FKBP-70 with 
other proteins 
The amino acid sequences of peptides A and B and their 
connecting sequence as derived from the initial PCR product, 
revealed high similarity to members of the FKBP family includ- 
ing FKBP-12 and FKBP-13 from yeast (Fig. 3~). Subsequent 
isolation and sequencing of a yeast DNA fragment from pFC1 
identified a reading frame of 1233 bp encoding a novel protein 
of 411 amino acids (Fig. 2). Detection of a 1.5 kb messenger 
RNA by Northern analysis (data not shown) and the presence 
of upstream transcription regulatory sequences were consistent 
with the length of the reading frame. This structural gene for 
the novel FKBP was designated FPR3 (FK-bindingproline rota- 
mase 3), consistent with the nomenclature of previously identi- 
fied yeast FKBPs, FPRI and FPR2 [&lo]. 
Comparison of FKBP-70 with existing sequence databases 
revealed two separate regions of homology to previously 
known proteins. The carboxy-terminal quarter of the molecule 
(321411) was homologous to the other yeast FKBP proteins 
(Fig. 3c) as well as the non-yeast members of the FKBP im- 
munophilin family (data not shown). The high degree of conser- 
vation included the residues involved in drug binding and 
constituting the rotamase active site (see legend, Fig. 3~). Re- 
combinant FKBP-70 showed FK-506 sensitive rotamase activ- 
ity as measured by the method of Kofron et. al [32], albeit six 
fold lower than recombinant human FKBP-12 (Fig. 4). 
The region of FKBP-70 extending from amino acids 41 to 
266 is extremely rich in acidic residues (99 out of 226). The 
primary sequence from residues 41 to 300 contains several 
clusters of negatively charged residues and four positively 
charged regions. This kind of charge clusters in polypeptides 
have been implicated in membrane association and nuclear 
localization [ 191. Amino acids 209 to 270 show high homology 
(32161 identical) to a region (amino acids 239 to 297) of Chinese 
hamster nucleolin ([20] and Fig. 3b) and its coun- 
terparts in other vertebrates [21]. In this alignment the func- 
tional nuclear localization signal (NLS) of nucleolin 
(KRKKEMTKQKEVPEAKKQK, positions 279-297) is dis- 
played at the carboxy-terminal end [22]. Potential NLSs [23] in 
FKBP-70 include the homologous sequence KSKKEKKRK- 
HEEKEEEKKAKK, (residues 251-270) as well as other 
stretches of basic amino acids (in particular KKKKSKGKK, 
residues 91-99). The acidic domain of nucleolin has been shown 
to regulate chromosome decondensation [24], and bind to the 
NLSs of other proteins destined for import into the nucleus 
[25]. However, the RNA binding domain and Gly/Arg domains 
of nucleolin, important for its localization and function in the 
nucleolus [26], have no counterpart in FKBP-70. A mammalian 
protein with a similar FKBP domain, FKBP-25, that localizes 
to the nucleolus and associates with casein kinase II and nucle- 
olin was recently described [27]. FKBP-70 may play a role in 
protein folding in the nucleus, analogous to that of FKBP-12 
in the cytosol [28], and of FKBP-13 in the endoplasmic reticu- 
lum [29]. The unique aminoterminal portion of the FKBP-70 
may be responsible for its localization and target specificity, 
while the rotamase domain would participate in the protein 
folding functions. 
3.3. Expression of FKBP-70 in E. coli 
The calculated molecular weight of FKBP-70, based on its 
amino acid sequence, is 46.5 kDa, and is different from the 
observed size of 70 kDa. The recombinant FKBP-70, purified 
from E. cofi displayed an electrophoretic mobility of approxi- 
mately 69 kDa (Fig. lB, lane 3) raising the possibility that, in 
yeast, FKBP-70 may have additional post translational modifi- 
cations. Sequencing of the recombinant protein confirmed the 
initial 30 amino acids residues. We conclude that the cloned 
gene encodes the complete protein and that its abnormal migra- 
tion in SDS-PAGE is due to its primary sequence. Its high 
content of acidic amino acid (theoretical p1 4.2) might be re- 
sponsible for this aberrant migration, as reported for the 
clathrin assembly protein AP180 [30]. 
3.4. Disruption of the FPR3 gene 
Disruption mutants of FPR3, interrupting the coding region 
at proline 127 in the structural gene, were viable, indicating that 
FKBP-70 is not essential for vegetative growth. Therefore, all 
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agggatttcaggtatcaaagtcgcattgacgtataaaatactccaaaaaatgcgctctgt 
ttactttattatctatgaaataagaaaaatgcaaccggtgagtgtaaaagcatcctgcaa - -- 
gaatttgttacaacttcatctcagttaccaacatagccaacggacgtcgatattgtcctE 
taccccactggtagtgaaatactttcgagtaaatgtcaggacgttagaaatcatccgagt 
catgcttcgactccatgtatttttattctctaagtgtgctttggaatttccccgcgagtt 
ctcacagaattggctttactgccaaaagttgaagacagcatagtcattggcttcgtcaaa 
agatcttcattatttaaagcaagcaatgatcaattctaagacgggttaacaaaatatgga 
cagagcatcttcaagcaaaactaatcgccggcaatgttaagcttacatatattcgaacgg 
taataacatcgataatacggttatagccaccaactctgcattatagaaatgagaaaagcg 
ccatagctattatttaacgtaacttaccagaagtccttgagcagacgattgagcattgaa 
taaaaaataaaattcttgtaattcttggaaggaagaacgacacaaatagataaatggcgt 
attttctgagcaatgaactgtgttccatcaaaaacattttatcgcacaccataggcactt 
agaaaaacaaacctttgtgccagtatttgaatgaaaacactttggttgaaatgtattgtg 
aaattaatcatcgagcactttacggttggcaacgacacattactgacgttctttcgccga 
tttgttactttaatatattgtacaaaaatgcatcaaagaacataaaagagagcgatcgca 
caatcaaacttcttttggaaataatctgtcatcaatgctccaaacattctactatcacct 
gttcatgatattatggggagaatatgccaaatgtatatgacacatcgcatactttctacc 
tttttcaactggcttgcttcctctttcacctttcactaaaatctggattgcatctacatctat 
atagtcaaaaccggcaagaacagagattatgatacatgcttcatgttccattgattagaa 
tccactagtattagctcgctgttcaattttcagccctctacggactgtcgtcattcctaa 
aggacggcaaaatttaaaagtgaaggtaaaatttttaaattcgaaaaaagagcctactaa 
cacgtttctatltaatacataattgtgtgaaagttcatacataattgaaagcaagcatcc 
aaccagcccaatatgtctgatttgttaccactagctacctacagtttgaatgttgaacct 
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tataccccggttccagcaatcgacgtcacgatgcccatcaccgttcgtattactatggct 
YTPVPAIDVTMPITVRITMA 
gctttgaacccggaagccatcgatgaagagaaccatcgactttaagaattatcaaa 
ALNPEAIDEENKPSTLRIIK 
agaaacccggactttgaagatgatgattttttaggtggtgattttgatgaagacgaaata 
RNPDFEDDDFLGGDFDEDEI 
gacgaagaatcctctgaggaagaagaagaggaaaaaacccaaaagaaaaagaagagtaaa 
16 
36 
56 
76 
96 DEESSEEEEEEKTQKKKKSK 
ggcaagaaggctgaaagtgaaagtgaggatgatgaagaagacgatgacgaggacgatgag 
GKKAESESEDDEEDDDEDDE 116 
ttccaagaatccgtccttttgactttatctccggaagcccaataccaacaatctttaaac 
F Q ii S v L L-T L S P-k ii Q Y Q Q S L-b 136 
ttgaccattactccagaagaagaagtccaattcattgtcactggttcttacgctatctcc 
LTITPEEEVQFIVTGSYAIS 156 
ttgagcggtaactatgttaagcatccatttgatactccaatgggagtcgaaggtgaagac 
LSGNYVKHPFDTPMGVEGED 176 
gaagatgaagacgctgacatctatgacagtgaagactacgacttgaccccagatgaggat 
EDEDADIYDSEDYDLTPDED 196 
gaaattattggcgacgacatggacgacttggatgacgaagaggaagaagaagttcgtatt 
EIIGDDMDDLDDEEEEEVRI 216 
gaagaagtccaagaagaagatgaagaagataatgatggagaagaagaacaagaagaagaa 
EEVQEEDEEDNDGEEEQEEE 236 
gaagaagaagaacaaaaagaagaagttaagccagaacctaagaaaagcaaaaaggaaaaa 
EEEEQKEEVKPEPKKSKKEK 256 
aagagaaagcacgaagagaaagaagaagaaaagaaagctaaaaaagtaaagaaggtcgaa 
KRKHEEKEEEKKAKKVKKVE 276 
ttcaagaaggacttagaggagggtccaacaaaacccaaaagcaaaaaggaacaagataag 
FKKDLEEGPTKPKSKKEQDK 296 
cataaaccaaagagtaaggttttggaaggcggcatagtaatcgaagaccgtactatcggt 
HKPKSKVLEGGIVIEDRTIG 316 
2461 gatggcccacaggctaagagaggtgccagagtaggcatgaggtacattggtaagttaaag 
2521 
DGPQAKRGARVGMRYIGKLK 336 
aacggtaaagttttcgacaagaacaccagcggtaaaccatttgcattcaaacttggccgt 
NGKVFDKNTSGKPFAFKLGR 356 
2581 ggtgaagttatcaaaggctgggacattggtgttgccggtatgtctgttggtggcgaacgt 
GEVIKGNDI~VA~YBVGGER 376 
2641 agaatcatcattccagcaccatatgcctacgggaagcaagctctgccaggtattcctgcc 
RIIIPAPYAYGKPALPQIPA 396 
2701 aattccgaactgacattcgacgttaaattggtttctatgaaaaactagtacacgcgctcg 
N S E LTFDV K LVSM KN stop 411 
2761 tacggatagatgtttatatatattctttctttttacataatattgtaaccttctgtatgta 
2821 aatccgaaaacattctatttctttttagtatctattgctctttataagcttttcatttta 
pm; ~~~ttctccgcccatgatacaaataaagaagctgtgttgtatagaaagaaatatatggcg 
Fig. 2. Nucleotide sequence of the cloned FPR3 gene (numbered on the left) and amino acid sequence of the FKBP70 protein (numbered on the 
right). A potential promoter element is indicated on the nucleotide sequence (bold, underlined). Partial protein sequence obtained from internal 
peptides (underlined), as well as peptide sequence used to derive PCR primers (bold) is indicated. 
three members of the FPR gene family, FPRI, FPR2 and FPR3, role are the two homologous FPRI and FPR2 rotamases, al- 
share this characteristic ([8,9] and this work). We were unable though specific subcellular compartmentalisation of these pro- 
to observe altered growth phenotypes in strains disrupted for teins may prevent them from compensating for each other. We 
FPR3 under different conditions of temperature, osmolarity, have examined this possibility by constructing a triple mutant 
pH of the growth medium or in the presence of ascomycin. The yeast strain, simultaneously disrupted for the three FPR genes. 
FPR3 null mutants would survive if FKBP-70 did not encode As this strain was viable, we conclude that the yeast strains can 
an essential function or if this function could be provided by survive with the reduction in the isomerase activity contributed 
other genes. If the latter were the case, mutations in multiple by these three proteins and the survival of individual FPR null 
genes would be required for defective growth phenotypes. mutants cannot be a consequence of one of the other two 
Southern blot analysis of genomic DNA from haploid strains homologous genes compensating for its function. Neither low 
with an FPR3 probe indicated that it is present as a single copy nor high copy number yeast plasmids with the cloned FPR3 
gene (data not shown). Other likely candidates for this shared gene inhibited the growth of wild type yeast strains on selective 
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3a. 
3b. 
210 220 230 240 250 260 270 
FKBP70 EEEEE-VRIEEVQEEDEEDNDGEEEEQEEEEEEEQKE~KPEPKKSKKEKKRKHEEKEEEK~K~K 
II::: II :I::III:::Il::IIIIIII:.I.III.I 1.111.. I:.I .l.II.I 
NucH EEDDDD---EEEDEDEEEDEEEEEDEEEEEEEEEEEPVKPAPGKRKKEMT-KQKEVPEAKKQKV 
240 250 260 270 280 290 298 
3c. 
FKBP-12 SEVIEGNVKI-DRISPGDGATFPKTGDLVTIHYTGTL-ENGQKFDSSVDRGSPFQCNIGV 
FKBP-13 GSLSDLEIGIIKRIPVEDCLIKAMPGDKVKVHYTGSLLESGTVFDSSYSRGSPIAFELGV 
FKBP-70 AKRGARVGMRYIGKL-KNGKVFDKN-TSGKPFAFKLGR 
. . l . * .*.* * ..* .**.. .*.+.*. .*. 
FKBP-12 GQVIKGWDVGIPKLSVGEKARLTIPGPYAYGPRGFPGLIPPNSTLVFDVELLKVN 
FKBP-13 GRVIKGWDQGVAGMCVGEKRKLQIPSSLAYGERGVPGVIPPSADLVFDVELVDVKSAA 
FKBP-70 GEVIKGWDIGVAGMSVGGERRIIIPAPYAYGKQALPG-IPANSELTFDVKLVSMKN 
1 t***t* l l * ++ . . . . . . . . . . ..*++ . . l * l *... l .***.*. . . 
Fig. 3. (a) Domain organization of the FKBP-70 protein, indicating point of disruption with the LEU2 gene fragment (black). Numbers indicate 
key aminoacid residues. Acidic domain (dark and light gray), with region of homology to nucleolin (light gray) and immunophilin homology domain 
(FKBP domain) are highlighted. Arrowheads indicate C-terminus. NLS?, potential nuclear localization signals (hatched). (b) Sequence comparison 
between FKBP70 and Hamster nucleolin (NucH), showing the region of highest homology using GAPcomputer program (UW-GCG). Residues 
identical (I), highly conserved (:), and less conserved c) are indicated. (c) Homology among FKBP proteins of S. cerevisiae. The complete amino 
acid residues of FKBP-12 and FKBP-13, and the amino acid residues 321 to 411 of FKBP-70 were compared: (*) indicates identical residues; c) 
indicates common residues in any two proteins. The CLUSTAL multiple sequence alignment program (UW-GCG) was used. The amino acid residues 
Y331, F341, D342, 1360, W363, Y386, 1394 and F404 in FKBP-70 are not only conserved in all three yeast FKBP proteins, but the corresponding 
residues in human FKBP-12 were shown to interact directly with the FK-506 ligand in the crystals [18]. Similarly, the conserved signature sequence 
for the FKBP family of proteins [3] can be seen in FKBP-70 as YIGKLKNGKVFDKN (aa 331-344, bold letters indicating the identical residues). 
1.6 r 
-A- rFKBP12 
0.6 
I 
00:45 01:35 02:25 03:15 04:05 04:55 05:45 
time [min:sec] 
Fig. 4. Peptidyl-prolyl isomerase (PPIase) activity of recombinant 
FKBP-70 as measured by the method of Kofron et al. [32]. The data 
is generated by using 100 nM recombinant human FKBP-I2 
(rFKBP12) and 660 nM recombinant FKBP-70 (fkbp70). FK506 was 
used at tenfold molar excess to inhibit the enyme reaction. 
media, suggesting that a high expression level of FKBP-70 is 
not toxic to yeast. 
In summary, we characterized a novel member of the FPR 
gene family in yeast and showed that its presence is not essential 
for growth under normal conditions. However, conditional 
growth phenotypes were observed for other immunophilins in 
yeast [28,29,31]. A better understanding of the physiological 
role of FKBP-70 may require screening for its synthetic lethal- 
ity with mutations in other yeast proteins. 
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